Clinical Trials Logo

Labor, Induced clinical trials

View clinical trials related to Labor, Induced.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05857059 Recruiting - Obesity Clinical Trials

Misoprostol for Induction of Labor in Obese Women: Comparison Between 25 and 50 mcg Oral Administration

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

In recent decades, obesity has become a prevalent issue in Portugal, with 38.6% and 13.8% of the population being overweight or obese, respectively. Obese pregnant women have a higher rate of obstetric complications, including hypertensive complications, gestational diabetes and fetal macrosomia, leading to increased induction of labor (IOL) and cesarean section (CS) rates. To determine the effect of increasing oral misoprostol dose on CS rate in obese pregnant women undergoing IOL, a randomized controlled trial with a sample size of 114 cases in each group was calculated to detect a 15% difference in CS rate. The primary objective is to determine the effect of increasing oral misoprostol dose, with secondary goals being to compare successful IOL rates and their relationship with oral misoprostol dose, as well as to evaluate tolerability and side effects in relation to different doses of oral misoprostol.

NCT ID: NCT05177510 Recruiting - Labor, Induced Clinical Trials

Mifepristone Outpatient Labour Induction

MOLI
Start date: August 25, 2023
Phase: Phase 3
Study type: Interventional

The number of women having an induction of labour is increasing and is currently used in 33% of pregnancies for a range of medical reasons. The majority of women are admitted to hospital to have their labour induced, using methods which are protracted and associated with a poor birth experience, making them both costly and unpopular. Further, current methods of outpatient induction are unsuitable, unsafe and/or have a poor acceptability. The COVID-19 pandemic has driven a reduction in the number of face-to-face interactions taking place across all areas of medicine. Proving the efficacy and safety of Mifepristone would significantly reduce pre-labour admission rates and hospital length of stay for pregnant women, who are at particularly higher risk of COVID-19, and reduce delivery costs.

NCT ID: NCT02902653 Recruiting - Labor, Induced Clinical Trials

Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction

Start date: September 2016
Phase: Phase 4
Study type: Interventional

This study evaluates the efficacy and safety of the administration of oral misoprostol versus vaginal dinoprostone and vaginal misoprostol for cervical ripening and labor induction.

NCT ID: NCT02486679 Recruiting - Labor, Induced Clinical Trials

A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction

Start date: July 2015
Phase: Phase 4
Study type: Interventional

A randomized controlled trial comparing labor induction with vaginal PGE2 tablets and foley catheter for cervical ripening.